Agenda

Thursday, February 15, 2018

07:00 a.m. – 05:00 p.m.
Symposium Registration
 

08:00 a.m. – 05:30 p.m.
Pre-Symposium Workshops:
 

Pre-Symposium Workshop #1: 09:00 a.m. – 04:55 p.m.: New Concepts in Locoregional Therapy of Breast Cancer[/right]

Breast Conserving Therapy and Axillary Management

08:00 a.m. – 08:20 a.m.: Sutureless, Stereotactic, Minimally-Invasive, Intact Excision of High Risk Breast Lesions – Pat W. Whitworth, MD

08:20 a.m. – 08:40 a.m.: Advances in Wireless Approaches to BCT#1 – Peter W. Blumencranz, MD

08:40 a.m. – 09:00 a.m.: Advances in Wireless Approaches to BCT#2 – Henry M. Kuerer, MD, PhD

09:00 a.m. – 09:20 a.m.: Lumpectomy Margin Management – Stephen R. Grobmyer, MD

09:20 a.m. – 09:40 a.m.: Role of Novel Specimen Imaging to Evaluate Specimen Margins – Dalliah M. Black, MD

09:40 a.m. – 10:00 a.m.: New Directions in Accelerated Partial Breast Irradiation – David E. Wazer, MD

10:00 a.m. – 10:20 a.m.: BREAK

10:20 a.m. – 10:40 a.m.: Nodal Downstaging – A New Indication for Neo-Adjuvant Therapy – Henry M. Kuerer, MD, PhD

10:40 a.m. – 11:00 a.m.: Fluorescence Based Approaches to Sentinel Node Surgery – Stephen R. Grobmyer, MD

11:00 a.m. – 11:20 a.m.: Preventing Lymphadema – The Role of Bioimpedence – Pat W. Whitworth, MD

11:20 a.m. – 11:40 a.m.: Lymphatico-venous Bypass: A New Concept for Preventing Lymphadema – Risal Djohan, MD and Stephen R. Grobmyer, MD

11:40 a.m. – 12:00 p.m.: Panel Discussion – Dalliah M. Black, MD; Peter W. Blumencranz, MD; Stephen R. Grobmyer, MD; Henry M. Kuerer, MD, PhD; David E. Wazer, MD; and Pat W. Whitworth, MD

12:00 p.m. – 01:00 p.m.: LUNCH

 

Mastectomy and Reconstruction

01:00 p.m. – 01:20 p.m.: Pain Management Following Mastectomy – Risal Djohan, MD

01:20 p.m. – 01:40 p.m.: Nipple Sparing Mastectomy (NSM) – Case Selection – Armando E. Giuliano, MD

01:40 p.m. – 02:00 p.m.: 1 Stage Breast Reconstruction – Risal Djohan, MD

02:00 p.m. – 02:10 p.m.: BREAK

02:10 p.m. – 02:30 p.m.: Managing Acute Reconstruction Failures – Risal Djohan, MD

02:30 p.m. – 02:50 p.m.: Incision placement and NSM-TUGI Approach – Stephen R. Grobmyer, MD

02:50 p.m. – 03:10 p.m.: Advances in Autologous Reconstruction with Sensory Preservation – Risal Djohan, MD

03:10 p.m. – 03:40 p.m.: Panel Discussion – Risal Djohan, MD; Armando E. Giuliano, MD; and Stephen R. Grobmyer, MD

03:40 p.m. – 04:00 p.m.: BREAK

04:00 p.m. – 05:30 p.m.: Station 1:
                                       Station 2: 
                                       Station 3: 
                                       Station 4: 
                                       Station 5: 
                                       Station 6: 
                                       Station 7: 
                                       Station 8: 
                                       Station 9: 
                                       Station 10: 
                                       Station 11: 
                                       Station 12:

Pre-Symposium Workshop #2: 01:00 p.m. – 05:00 p.m.: Difficult to Diagnose Cases in Breast Pathology

Shahla Masood, MD, Stuart J. Schnitt, MD, Sandra J. Shin, MD
 

01:00 p.m. – 01:30 p.m.: Pattern Based Approach to Interpretation of Core Needle Biopsy – Sandra J. Shin, MD

01:30 p.m. – 02:00 p.m.: Which High Risk Lesions on Core Needle Biopsy Require Excision in Current Practice? – Stuart J. Schnitt, MD

02:00 p.m. – 02:30 p.m.: Mimickers of Breast Lesions – Sandra J. Shin, MD

02:30 p.m. – 03:00 p.m.: BREAK

03:00 p.m. – 03:30 p.m.: The Spectrum of Triple Negative Neoplasia – Stuart J. Schnitt, MD

03:30 p.m. – 04:00 p.m.: Columnar Cell Lesions, Flat Epithelial Atypia, Low Grade Neoplasia Family – Sandra J. Shin, MD

04:00 p.m. – 04:30 p.m.: Interactive Case Review: Self-Assessment – Shahla Masood, MD

04:30 p.m. – 05:00 p.m.: Panel Discussion – Shahla Masood, MD; Stuart Schnitt, MD; Sandra J. Shin, MD

 

Pre-Symposium Workshop #3: 01:00 p.m. – 04:00 p.m.: An Update on Breast Cancer Risk and Genetic Testing
Banu Arun, MD, Molly S. Daniels, MS, CGC; Claudine Isaacs, MD, Shahla Masood, MD, Freya Schnabel, MD, and Marie Wood, MD
 

01:00 p.m. – 01:30 p.m.: Breast Cancer Risk Factors and Global Risk Assessment – Freya Schnabel, MD

01:30 p.m. – 02:00 p.m.: Importance of Family History and Indications for Genetic Testing – Marie Wood, MD

02:00 p.m. – 02:30 p.m.: Update on Genetic Testing Panels – Banu Arun, MD

02:30 p.m. – 03:00 p.m.: BREAK

03:00 p.m. – 03:30 p.m.: Clinical Management of High Risk Patients – Claudine Isaacs, MD

03:30 p.m. – 04:00 p.m.: Morphologic Risk Factors: Diagnostic Issues and Clinical Significance – Shahla Masood, MD

04:00 p.m. – 04:30 p.m.: Ethical and Psycho-Social Issues Related to Genetic Testing – Molly S. Daniels, MS, CGC

04:30 p.m. – 05:00 p.m.: Panel Discussion – Banu Arun, MD; Molly Daniels, MS, CGC; Claudine Isaacs, MD; Shahla Masood, MD; Freya Schnabel, MD; and Marie Wood, MD

 

Friday, February 16, 2018

07:00 a.m. – 08:00 a.m.
Registration, Breakfast and Exhibits
 

08:00 a.m. – 08:05 a.m.
Introductory Remarks – Shahla Masood, MD
 

08:05 a.m. – 08:15 a.m.
Introduction of Keynote Speaker – Armando E. Giuliano, MD
 

08:15 a.m. – 09:00 a.m.
Keynote Lecture – Why Dose-Dense Chemotherapy Works and What it Means About the Nature of Neoplasia – Larry Norton, MD
 

Session I  – New Trends in Breast Cancer Diagnosis and Therapy

Moderators
Gary H. Lyman, MD
 

09:00 a.m. – 09:30 a.m.
New Technologies for Breast Cancer Screening: What are they and What Kind of Cancers do They Detect? – Maxine S. Jochelson, MD
 

09:30 a.m. – 10:00 a.m.
Management of High Risk Lesions – Gary J. Whitman, MD
 

10:00 a.m. – 10:30 a.m.
BREAK AND EXHIBITS
 

10:30 a.m. – 11:00 a.m.
Does Every Breast Cancer Patient Need a Staging MRI? – Gary J. Whitman, MD
 

11:00 a.m. – 11:30 a.m.
 Who Knew Imaging the Axilla Could be so Complicated? – Maxine S. Jochelson, MD
 

11:30 a.m. – 12:00 p.m.
 Panel Discussion – Maxine S. Jochelson, MD; Gary H. Lyman, MD; Larry Norton, MD; and Gary J. Whitman, MD
 

12:00 p.m. – 01:00 p.m.
LUNCH & EXHIBITS
 

 


Session II – New Advances in Breast Cancer Diagnosis and Therapy 

Moderators
Scott Lind, MD
 

01:00 p.m. – 01:30 p.m.
Nonoperative Management of DCIS – Thomas B. Julian, MD
 

01:30 p.m. – 02:00 p.m.
Eliminating Breast Cancer Surgery after Neoadjuvant Therapy: Will it be a New Trend? – Henry M. Kuerer, MD, PhD
 

02:00 p.m. – 02:30 p.m.
Current NSABP and NRG Oncology Trials – Thomas B. Julian, MD
 

02:30 p.m. – 03:00 p.m.
BREAK & EXHIBITS
 

03:00 p.m. – 03:30 p.m.
Optimizing Patient Selection and the Approach to Partial Breast Irradiation – David E. Wazer, MD
 

03:30 p.m. – 04:00 p.m.
Molecular Profiling in Breast Cancer: Ready for Prime Time? – Nicole M. Kuderer, MD
 

04:00 p.m. – 04:30 p.m.
Modern Immune Therapy Strategies for the Treatment of Breast Cancer – Heather L. McArthur, MD
 

04:30 p.m. – 05:00 p.m.
PANEL DISCUSSION – Thomas B. Julian, MD; Nicole M. Kuderer, MD; Henry M. Kuerer, MD, PhD; Scott Lind, MD; Heather L. McArthur, MD; and David E. Wazer, MD
 

 

 

Saturday, February 17, 2018

07:00 a.m. – 08:00 a.m.
Registration, Breakfast and Exhibits
 


Session III – Current Trends in Surgical Management of Breast Cancer

Moderators
Armando E. Giuliano, MD
 

08:00 a.m. – 08:30 a.m.
Management of the Positive Sentinel Node: The 10-Year Results of ACOSOG Z0011 – Armando E. Giuliano, MD
 

08:30 a.m. – 09:00 a.m.
Management of the Axilla after Neoadjuvant Therapy – Henry M. Kuerer, MD, PhD
 

09:00 a.m. – 09:30 a.m.
Optimal Margins for Invasive and Non-Invasive Breast Cancer – Stuart J. Schnitt, MD
 

09:30 a.m. – 10:00 a.m.
 
BREAK AND EXHIBITS
 

10:00 a.m. – 10:30 a.m.
When Can Post-Lumpectomy Radiation be Omitted? – Bruce G. Haffty, MD
 

10:30 a.m. – 11:00 a.m.
Pre-Pectoral Breast Reconstruction – Risal Djohan, MD
 

11:00 a.m. – 11:30 a.m.
Bilateral Risk Reducing NSM: Evolving Trends and Long Term Outcomes – Stephen R. Grobmyer, MD
 

11:30 a.m. – 12:00 p.m.
PANEL DISCUSSION – Risal Djohan, MD; Armando E. Giuliano, MD; Stephen R. Grobmyer, MD; Bruce G. Haffty, MD; Henry M. Kuerer, MD, PhD; and Stuart J. Schnitt, MD
 

12:00 p.m. – 01:30 p.m.
LUNCH & EXHIBITS
 

Session IV  – Innovation in Breast Cancer Therapy

Moderators
Debu Tripathy, MD
 

01:30 p.m. – 02:00 p.m.
Advances in Neoadjuvant Breast Cancer Therapy – Debu Tripathy, MD
 

02:00 p.m. – 02:30 p.m.
An Overview of Management of Metastatic HER2 Breast Cancer – Gerardo Colon-Otero, MD
 

02:30 p.m. – 03:00 p.m.
Advances in Hormonal Therapy – Debu Tripathy, MD
 

03:00 p.m. – 03:30 p.m.
BREAK AND EXHIBITS
 

03:30 p.m. – 04:00 p.m.
 
Fertility Preservation in Breast Cancer Patients – Heather Macdonald, MD
 

04:00 p.m. – 04:30 p.m.
 
Repeat Irradiation for Local Recurrence after Breast Conservation: Is it Reasonable? – Julie Bradley, MD
 

04:30 p.m. – 05:00 p.m.
 
Panel Discussion – Julie Bradley, MD; Gerardo Colon-Otero, MD; Heather Macdonald, MD; and Debu Tripathy, MD
 

 

Sunday, February 18, 2018

07:00 a.m. – 08:00 a.m.
Registration and Breakfast
 


Session V – Contemporary Issues in Breast Cancer

Moderators
Thomas B. Julian, MD
 

08:00 a.m. – 09:00 a.m.
Tumor Conference – Case Presentation – Armando E. Giuliano, MD
 

09:00 a.m. – 09:30 a.m.
Evidence Based Post Treatment Surveillance in Early Stage Breast Cancer – Gary H. Lyman, MD
 

09:30 a.m. – 10:00 a.m.
Changes to the AJCC Staging System – Armando E. Giuliano, MD
 

10:00 a.m. – 10:30 a.m.
Measuring and Evaluating the Quality and Value of Breast Cancer Care – Gary H. Lyman, MD
 

10:30 a.m. – 11:00 a.m.
Management of Post-Menopausal Symptoms in Breast Cancer –  Heather Macdonald, MD
 

11:00 a.m. – 11:30 a.m.
Panel Discussion – Armando E. Giuliano, MD; Gary H. Lyman, MD; and Heather Macdonald, MD
 

11:30 a.m. – 12:00 p.m.
Closing Remarks –  Shahla Masood, MD
 

 

Tagged as: ,